As discussed previously, anti-VEGF drugs are the most common drugs used in the treatment of AMD [180], and recent studies utilizing nanoemulsion and polymeric micelle delivery of these drugs continue to show improved clinical utility. Here, VEGFA is linked to age-related macular degeneration.